Skip to main content
Equibles

Michael Brophy

CFO

Natera, Inc. (NTRA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Natera, Inc. publishes a filing, an earnings call transcript or a press release.

Get NTRA alerts

About Michael Brophy

Michael Brophy is recorded as CFO at Natera, Inc. (NTRA). The newest filing on record that lists Michael Brophy as CFO at Natera, Inc. (NTRA) is dated April 13, 2022. The proxy statement of Natera, Inc. reports total compensation of $3,139,345 for Michael Brophy in fiscal 2020, including a base salary of $409,152. Disclosed compensation is on record for 2 fiscal years. Michael Brophy has spoken on 21 earnings calls across 1 company, most recently for Natera, Inc. on August 6, 2026. Natera, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Natera, Inc. includes Steven L. Chapman (CEO), Matthew Rabinowitz (Chairman and Board Member), Robert A. Schueren (COO) and 7 others.

Michael Brophy on recent calls

“Thank you for joining our conference call to discuss the results of our second quarter of 2026. On the line, I'm joined by Steve Chapman, our CEO, Salman Moskovich, President, Clinical Diagnostics, and now Salession, General Manager of Oncology, and our Chief Medical Officer.”
CFO, Natera, Inc. Q2 Earnings Conference Call ·
“Thank you for joining our conference call to discuss the results of our first quarter of 2026. On the line, I am joined by Steve Chapman, our CEO, Solomon Moskovich, President of Clinical Diagnostics, and now Soloshan, General Manager of Oncology, and our Chief Medical Officer.”
CFO, Natera, Inc. Q1 FY2026 Earnings Call ·
“Thank you for joining our conference call to discuss the results of our fourth quarter of 2025.”
CFO, Natera, Inc. Q4 FY2025 Earnings Call ·
“Thank you for joining our conference call to discuss the results of our third quarter of 2025. On the line, I'm joined by Steve Chapman, our CEO, Solomon Moskovich, President of Clinical Diagnostics, and Alex Alessian, General Manager of Oncology, and our Chief Medical Officer.”
CFO, Natera, Inc. Q3 FY2025 Earnings Call ·
“Thank you for joining our conference call to discuss the results of our fourth quarter of 2024.”
CFO, Natera, Inc. Q4 FY2024 Earnings Call ·

Affiliation history

  • Natera, Inc. (NTRA)

    CFO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 13, 2022

Company network

Leadership on record at Natera, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Natera, Inc. (NTRA) $409,152 $3,139,345
2019 Natera, Inc. (NTRA) $354,035 $3,541,917

Recent activity

Show 9 earlier activities